Health knowledge made personal

HealthReformWatch.com

"Seeks to provide an open forum for academics, medical professionals, policy makers, journalists, lawyers, students and concerned citizens as we, as a country, attempt to navigate the imperative of health care reform." Author: Editor-in-chief Frank Pasquale is a professor and associate... Full Bio
› Share page:

Posts

Sort by: Most recent | Name
Suing Whistleblowers by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Charles A. Sullivan For every revolution, there is a counter-revolution, or at least an attempted one. And we’re beginning to see seri ... Read on »
Monday Morning Recap: The Week (2.9.15-2.15.15) in Drug & Device Law & Policy by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy This Tuesday edition of the Monday Morning Recap comes to you from the great and cold state of Vermont. The Monday Morning Recap is the w ... Read on »
As the Ebola Epidemic Turns a Corner, What Lessons Can We Learn? by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Carl H. Coleman Recent news from West Africa indicates that the Ebola epidemic is turning a corner. In late January, the World Health ... Read on »
FDA Guidance to Industry Streamlines Physician Compassionate Use Requests by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Jordan Paradise The Food and Drug Administration (FDA) published draft guidance for industry last week detailing a streamlined process ... Read on »
Monday Morning Recap: The Week (2.2.15-2.8.15) in Drug & Device Law & Policy by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy Well, after two snowy Mondays in a row, we’ve got…a wintry mix today. Time for the Monday Morning Recap, the post where we call out recen ... Read on »
Monday Morning Recap: The Week (1.26.15-2.1.15) in Drug & Device Law & Policy by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy Another snowy Monday here in Newark, another Monday Morning Recap, the post where we call out recent drug and device law and policy devel ... Read on »
Flu Vaccinations in the Workplace – What Health Care Employers Need to Know – Part Two by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By: Joseph C. O’Keefe, Daniel L. Saperstein, and Harry N. Hudesman Editor’s Note: You can read Part One of this post here. Precautionary ... Read on »
Flu Vaccinations in the Workplace – What Health Care Employers Need to Know – Part One by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By: Joseph C. O’Keefe, Daniel L. Saperstein, and Harry N. Hudesman Editor’s Note: Health Reform Watch is very pleased to welcome Joseph C ... Read on »
Monday Morning Recap: The Week (1.19.15-1.25.15) in Drug & Device Law & Policy by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy Another Monday, another Monday Morning Recap, the post where we call out recent drug and device law and policy developments that caught o ... Read on »
Recommended Reading: New Empirical Analysis of False Claims Act Whistleblower Litigation by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Kate Greenwood Cross-Posted at Bill of Health Late last year, the Columbia Law Review published David Freeman Engstrom’s Private Enfor ... Read on »
Speakers Announced for Upcoming SHU Law Behavioral Health Conference by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy Here’s the flyer for another great, free conference here at Seton Hall Law. This one will be held February 6th and will focus on insuranc ... Read on »
Monday Morning Recap: The Week (1.2.15-1.18.15) in Drug & Device Law & Policy by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy Here’s the Monday Morning Recap, this week on Tuesday due to the holiday, the post where we call out recent drug and device law and polic ... Read on »
A “Money Blind” for Research into Maternal-Fetal Medication Risk? by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Kate Greenwood Cross-Posted at Bill of Health A week ago, the Food and Drug Administration announced the results of a review of the me ... Read on »
Upcoming SHU Law Networking Event by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy For those in the area, Seton Hall Law’s Center for Health & Pharmaceutical Law & Policy is sponsoring what looks to be a great event next ... Read on »
Monday Morning Recap: The Previous Week (1.5.15-1.11.15) in Drug & Device Law & Policy by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy Happy New Year! After a break (during which, you may have noticed, Health Reform Watch has been undergoing a thorough update), we’re back ... Read on »
Politics, Law and the Real World: Reconciling the Disconnect Among the Supreme Court, Voters, and... by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Nina Trovato In the landmark 2012 decision, National Federation of Independent Business v. Sebelius, Chief Justice Roberts, writing for ... Read on »
The ‘Halbig Cases’: Partisan Interpretation? Time Will Tell by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Brandon Zarsky A string of recent cases across the country has dealt what many consider a heavy blow to the Obama Administration’s Pati ... Read on »
Medical Balance Billing – How Far is Too Far? by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Christine O’Neill Healthcare costs in the United States topped $3.8 billion in 2013 according to Forbes.com.  Industry experts offer ma ... Read on »
Mental Health and New York’s No-Gun List by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Tiffany Tagarelli New York has recently revealed its newly created database of New Yorkers determined to be mentally unstable and unabl ... Read on »
New Disclosure Law Shines Light on Prescribing Practices by HealthReformWatch.com Posted in: Blog Posts in Healthcare Industry & Policy By Jordan Paradise This week, the New York Times reported that ophthalmologists who were paid to promote Genentech’s drug Lucentis (ranibi ... Read on »